Abstract:Ye Liu, 1, &ast Lifan Zhang, 1– 4, &ast Yan Chen, 1, &ast Guiren Ruan, 1– 3 Yuchen Liu, 1 Shi Chen, 1 Lantian Xie, 1 Fengying Wu, 1 Xiaochun Shi, 1– 3 Xiaoqing Liu 1– 4 1 Division of Infectious Diseases, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 2 State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Beijing, People's Republic of China; 3 Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 4 Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaochun Shi; Xiaoqing Liu, Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan No. 1, Beijing, 100005, People's Republic of China, Email ; Background: The population with latent tuberculosis infection (LTBI) represents a potential pool of patients with active tuberculosis (ATB). T-SPOT.TB is an important test tool for screening LTBI. Owing to the large population of LTBI patients in China, it is necessary to identify a high-risk group for LTBI and enlarge tuberculosis preventive treatment (TPT) to reduce the incidence of ATB. Methods: Hospitalized patients with positive T-SPOT.TB results were recruited from January 2013 to December 2016. Patients with ATB were excluded. Basic information was collected and the development of ATBs was examined during follow-up. The life-table method was used to calculate cumulative incidence rates. Potential risk factors were analyzed through Cox regression analysis. Results: A total of 1680 patients with LTBI were recruited in the follow-up cohort, and 377 (22.44%) patients dropped out. With a median follow-up time of 81 months [interquartile range (IQR):61– 93], 19 of 1303 patients with LTBI developed ATB. The 1-year incidence of ATB was 614 per 100,000 individuals [95%confidence interval (95% CI):584– 644]. Over 5-year period, the cumulative incidence of ATB was 1496 per 100,000 [95% CI:1430– 1570], and the incidence density was 240 per 100,000 person-years[95% CI:144– 375]. In the Cox regression model, exposure of pulmonary tuberculosis (PTB) [adjusted hazard ratio (aHR)=10.557, 95% CI:2.273– 49.031], maximum daily dosage of glucocorticoids (GCs)≥ 50 mg/d (aHR=2.948, 95% CI:1.122– 7.748), leflunomide (LEF) treatment (aHR=8.572, 95% CI:2.222 − 33.070), anemia (aHR=2.565, 95% CI:1.015– 6.479) and T-SPOT.TB level≥ 300SFCs/10 6 PBMCs (aHR=4.195, 95% CI:1.365– 12.892) were independent risk factors for ATB development in LTBI patients. Conclusion: The incidence of ATB is significantly higher in hospitalized patients with LTBI than in the general population. The exposure history of PTB, maximum daily dosage of GCs≥ 50 mg/day, LEF treatment, anemia, and T-SPOT.TB level≥ 300SFCs/10 6 PBMCs, were the risk factors of tuberculosis reactivation. Hospitalized LTBI patients with the above factors may need TPT. Keywords: latent tuberculosis infection, active tuberculosis, incidence, risk factors Tuberculosis (TB) is an important infectious disease caused by Mycobacterium tuberculosis (MTB) that threatens human health. The Global TB Report 2022 noted that 10.6 million new TB cases were diagnosed in 2021, increasing of 3.6% over the previous year. China is one of the 30 high-burden countries. The WHO Health Organization estimated that China has 780,000 new TB patients, with an incidence of 55 per 100,000 in 2021. 1 The cumulative incidence of TB has reduced by only 11% from 2015 to 2021, far from the target of the Global End TB Strategy, which states that the incidence of TB should be reduced by 20% in 2020. 2,3 Latent tuberculosis infection (LTBI) is defined as a persistent immune response to stimulation by MTB antigens without active tuberculosis (ATB). LTBI has a 5% to 10% lifetime risk of progressing to ATB, mostly within 5 years of the initial infection. 4 There are two methods recommended by WHO for screening LTBI: tuberculin skin test (TST) and Interferon-γ release assays (IGRAs), including T-SPOT.TB. 5 The prevalence was estimated to be 20.3%, with nearly 300 million cases in China. 6 S -Abstract Truncated-

Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study

Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study

Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis

Latent Tuberculosis Infection in Rural China: Baseline Results of a Population-Based, Multicentre, Prospective Cohort Study

Prevalence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases: a Multi-Center, Cross-Sectional Study in China

Effect of Different Interventions for Latent Tuberculosis Infections in China: a Model-Based Study

Progress on Diagnosis and Treatment of Latent Tuberculosis Infection

High Latent TB Infection Rate and Associated Risk Factors in the Eastern China of Low TB Incidence.

Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China

Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study

Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China

Prevalence And Risk Factors For Latent Tuberculosis Infection Among Health Care Workers In China: A Cross-Sectional Study

[Prevalence and Risk Factors of Latent Tuberculosis Infection in Close Contacts of Tuberculosis Patients among Non-Resident Populations in Shanghai, China].

Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study

The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study

The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study

Latent Tuberculosis Infection among Close Contacts of Non-Residential Pulmonary Tuberculosis Patients in Shanghai, China

Use of the T-SPOT.TB Assay to Screen Latent Tuberculosis Infection among the TB Contacts in Shanghai, China.

Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study

The prevalence of latent tuberculosis infection in rural Jiangsu, China.

Incidence and risk factors of active tuberculosis among older individuals with latent tuberculosis infection: a cohort study in two high-epidemic sites in eastern China